| Year |
Citation |
Score |
| 2011 |
Bongiorno D, Schuetz F, Poronnik P, Adams DJ. Regulation of voltage-gated ion channels in excitable cells by the ubiquitin ligases Nedd4 and Nedd4-2 Channels. 5: 79-88. PMID 21057195 DOI: 10.4161/Chan.5.1.13967 |
0.576 |
|
| 2008 |
Schuetz F, Kumar S, Poronnik P, Adams DJ. Regulation of the voltage-gated K+ channels KCNQ2/3 and KCNQ3/5 by serum- and glucocorticoid-regulated kinase-1 American Journal of Physiology - Cell Physiology. 295: C73-C80. PMID 18463232 DOI: 10.1152/Ajpcell.00146.2008 |
0.617 |
|
| 2007 |
Ekberg J, Schuetz F, Boase NA, Conroy SJ, Manning J, Kumar S, Poronnik P, Adams DJ. Regulation of the voltage-gated K(+) channels KCNQ2/3 and KCNQ3/5 by ubiquitination. Novel role for Nedd4-2. The Journal of Biological Chemistry. 282: 12135-42. PMID 17322297 DOI: 10.1074/Jbc.M609385200 |
0.45 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2009 |
Rom J, von Minckwitz G, Marmé F, Ataseven B, Kozian D, Sievert M, Schlehe B, Schuetz F, Scharf A, Kaufmann M, Sohn C, Schneeweiss A. Phase I study of apoptosis gene modulation with oblimersen within preoperative chemotherapy in patients with primary breast cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 20: 1829-35. PMID 19605509 DOI: 10.1093/annonc/mdp208 |
0.143 |
|
| 2011 |
Schott S, Bierhaus A, Schuetz F, Beckhove P, Schneeweiss A, Sohn C, Domschke C. Therapeutic effects of metformin in breast cancer: involvement of the immune system? Cancer Immunology, Immunotherapy : Cii. 60: 1221-5. PMID 21681370 DOI: 10.1007/s00262-011-1062-y |
0.136 |
|
| 2014 |
Schneeweiss A, Seitz J, Smetanay K, Schuetz F, Jaeger D, Bachinger A, Zorn M, Sinn HP, Marmé F. Efficacy of nab-paclitaxel does not seem to be associated with SPARC expression in metastatic breast cancer. Anticancer Research. 34: 6609-15. PMID 25368265 |
0.128 |
|
| 2017 |
Rathinasamy A, Domschke C, Ge Y, Böhm HH, Dettling S, Jansen D, Lasitschka F, Umansky L, Gräler MH, Hartmann J, Herold-Mende C, Schuetz F, Beckhove P. Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1. Cancer Immunology, Immunotherapy : Cii. PMID 28224210 DOI: 10.1007/s00262-017-1964-4 |
0.126 |
|
| 2013 |
Fremd C, Schuetz F, Sohn C, Beckhove P, Domschke C. B cell-regulated immune responses in tumor models and cancer patients. Oncoimmunology. 2: e25443. PMID 24073382 DOI: 10.4161/onci.25443 |
0.124 |
|
| 2016 |
Domschke C, Schneeweiss A, Stefanovic S, Wallwiener M, Heil J, Rom J, Sohn C, Beckhove P, Schuetz F. Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of Immunotherapy. Breast Care (Basel, Switzerland). 11: 102-7. PMID 27239171 DOI: 10.1159/000446061 |
0.119 |
|
| 2005 |
Schneeweiss A, Schuetz F, Rudlowski C, Hahn M, Lauschner I, Sinn HP, von Fournier D, Sohn C. Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trial. Anti-Cancer Drugs. 16: 1023-8. PMID 16162980 |
0.115 |
|
| 2013 |
Domschke C, Ge Y, Bernhardt I, Schott S, Keim S, Juenger S, Bucur M, Mayer L, Blumenstein M, Rom J, Heil J, Sohn C, Schneeweiss A, Beckhove P, Schuetz F. Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial. Cancer Immunology, Immunotherapy : Cii. 62: 1053-60. PMID 23595207 DOI: 10.1007/s00262-013-1414-x |
0.115 |
|
| 2009 |
Schuetz F, Ehlert K, Ge Y, Schneeweiss A, Rom J, Inzkirweli N, Sohn C, Schirrmacher V, Beckhove P. Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study. Cancer Immunology, Immunotherapy : Cii. 58: 887-900. PMID 18998129 DOI: 10.1007/s00262-008-0605-3 |
0.115 |
|
| 2012 |
Ge Y, Domschke C, Stoiber N, Schott S, Heil J, Rom J, Blumenstein M, Thum J, Sohn C, Schneeweiss A, Beckhove P, Schuetz F. Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome. Cancer Immunology, Immunotherapy : Cii. 61: 353-62. PMID 21915801 DOI: 10.1007/s00262-011-1106-3 |
0.115 |
|
| 2007 |
Eichbaum MH, Schuetz F, Khbeis T, Lauschner I, Foerster F, Sohn C, Schneeweiss A. Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study. Anti-Cancer Drugs. 18: 963-8. PMID 17667603 DOI: 10.1097/CAD.0b013e328165d11a |
0.114 |
|
| 2016 |
Fremd C, Stefanovic S, Beckhove P, Pritsch M, Lim H, Wallwiener M, Heil J, Golatta M, Rom J, Sohn C, Schneeweiss A, Schuetz F, Domschke C. Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patients. Oncoimmunology. 5: e1057387. PMID 26942066 DOI: 10.1080/2162402X.2015.1057387 |
0.114 |
|
| 2006 |
Thuerigen O, Schneeweiss A, Toedt G, Warnat P, Hahn M, Kramer H, Brors B, Rudlowski C, Benner A, Schuetz F, Tews B, Eils R, Sinn HP, Sohn C, Lichter P. Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 1839-45. PMID 16622258 DOI: 10.1200/JCO.2005.04.7019 |
0.111 |
|
| 2004 |
Schneeweiss A, Diel I, Hensel M, Kaul S, Sinn HP, Unnebrink K, Rudlowski C, Lauschner I, Schuetz F, Egerer G, Haas R, Ho AD, Bastert G. Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 15: 1627-32. PMID 15520063 DOI: 10.1093/annonc/mdh433 |
0.11 |
|
| 2008 |
Rom J, von Minckwitz G, Eiermann W, Sievert M, Schlehe B, Marmé F, Schuetz F, Scharf A, Eichbaum M, Sinn HP, Kaufmann M, Sohn C, Schneeweiss A. Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I study. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 19: 1698-705. PMID 18477581 DOI: 10.1093/annonc/mdn280 |
0.108 |
|
| 2009 |
Domschke C, Schuetz F, Ge Y, Seibel T, Falk C, Brors B, Vlodavsky I, Sommerfeldt N, Sinn HP, Kühnle MC, Schneeweiss A, Scharf A, Sohn C, Schirrmacher V, Moldenhauer G, et al. Intratumoral cytokines and tumor cell biology determine spontaneous breast cancer-specific immune responses and their correlation to prognosis. Cancer Research. 69: 8420-8. PMID 19843863 DOI: 10.1158/0008-5472.CAN-09-1627 |
0.108 |
|
| 2016 |
Hennigs A, Riedel F, Marmé F, Sinn P, Lindel K, Gondos A, Smetanay K, Golatta M, Sohn C, Schuetz F, Heil J, Schneeweiss A. Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade. Breast Cancer Research and Treatment. PMID 27744486 DOI: 10.1007/s10549-016-4016-4 |
0.108 |
|
| 2011 |
Domschke C, Schuetz F, Ge Y, Rom J, Zorn M, Sinn HP, Marmé F, Schott S, Heil J, Scharf A, Sohn C, Schneeweiss A, Beckhove P. Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients. Cancer Immunology, Immunotherapy : Cii. 60: 401-11. PMID 21161218 DOI: 10.1007/s00262-010-0956-4 |
0.107 |
|
| 2015 |
Stefanovic S, Diel I, Sinn P, Englert S, Hennigs A, Mayer C, Schott S, Wallwiener M, Blumenstein M, Golatta M, Heil J, Rom J, Sohn C, Schneeweiss A, Schuetz F, et al. Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate Treatment. Annals of Surgical Oncology. PMID 26467455 DOI: 10.1245/s10434-015-4895-3 |
0.105 |
|
| 2007 |
Rupp U, Schoendorf-Holland E, Eichbaum M, Schuetz F, Lauschner I, Schmidt P, Staab A, Hanft G, Huober J, Sinn HP, Sohn C, Schneeweiss A. Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study. Anti-Cancer Drugs. 18: 477-85. PMID 17351401 DOI: 10.1097/CAD.0b013e32801403f4 |
0.105 |
|
| 2016 |
Heil J, Schaefgen B, Sinn P, Richter H, Harcos A, Gomez C, Stieber A, Hennigs A, Rauch G, Schuetz F, Sohn C, Schneeweiss A, Golatta M. Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy? European Journal of Cancer (Oxford, England : 1990). 69: 142-150. PMID 27821317 DOI: 10.1016/j.ejca.2016.09.034 |
0.105 |
|
| 2015 |
Rauh C, Schuetz F, Rack B, Stickeler E, Klar M, Orlowska-Volk M, Windfuhr-Blum M, Heil J, Rom J, Sohn C, Andergassen U, Jueckstock J, Fehm T, Loehberg CR, Hein A, et al. Hormone Therapy and its Effect on the Prognosis in Breast Cancer Patients. Geburtshilfe Und Frauenheilkunde. 75: 588-596. PMID 26166840 DOI: 10.1055/s-0035-1546149 |
0.105 |
|
| 2011 |
Domschke C, Neubrech F, Dick M, Rom J, Beckhove P, Sohn C, Schuetz F, Scharf A. Intraoperative bone marrow puncture in breast cancer patients: prospective assessment of adverse side-effects. Breast (Edinburgh, Scotland). 20: 62-5. PMID 20621481 DOI: 10.1016/j.breast.2010.06.007 |
0.105 |
|
| 2013 |
Domschke C, Diel IJ, Englert S, Kalteisen S, Mayer L, Rom J, Heil J, Sohn C, Schuetz F. Prognostic value of disseminated tumor cells in the bone marrow of patients with operable primary breast cancer: a long-term follow-up study. Annals of Surgical Oncology. 20: 1865-71. PMID 23263703 DOI: 10.1245/s10434-012-2814-4 |
0.103 |
|
| 2017 |
Dinkic C, Jahn F, Zygmunt M, Schuetz F, Rom J, Sohn C, Fluhr H. PARP inhibition sensitizes endometrial cancer cells to paclitaxel-induced apoptosis. Oncology Letters. 13: 2847-2851. PMID 28454476 DOI: 10.3892/ol.2017.5795 |
0.101 |
|
| 2010 |
Domschke C, Schuetz F, Sommerfeldt N, Rom J, Scharf A, Sohn C, Schneeweiss A, Beckhove P. Effects of distant metastasis and peripheral CA 15-3 on the induction of spontaneous T cell responses in breast cancer patients. Cancer Immunology, Immunotherapy : Cii. 59: 479-86. PMID 19957084 DOI: 10.1007/s00262-009-0801-9 |
0.101 |
|
| 2016 |
Stefanovic S, Wallwiener M, Karic U, Domschke C, Katic L, Taran FA, Pesic A, Hartkopf A, Hadji P, Teufel M, Schuetz F, Sohn C, Fasching P, Schneeweiss A, Brucker S. Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 27747478 DOI: 10.1007/s00520-016-3437-2 |
0.1 |
|
| 2014 |
Foersterling E, Golatta M, Hennigs A, Schulz S, Rauch G, Schott S, Domschke C, Schuetz F, Sohn C, Heil J. Predictors of early poor aesthetic outcome after breast-conserving surgery in patients with breast cancer: initial results of a prospective cohort study at a single institution. Journal of Surgical Oncology. 110: 801-6. PMID 25132148 DOI: 10.1002/jso.23733 |
0.098 |
|
| 2014 |
Stefanovic S, Schuetz F, Sohn C, Beckhove P, Domschke C. Adoptive immunotherapy of metastatic breast cancer: present and future. Cancer Metastasis Reviews. 33: 309-20. PMID 24337953 DOI: 10.1007/s10555-013-9452-6 |
0.098 |
|
| 2015 |
Schaefgen B, Mati M, Sinn HP, Golatta M, Stieber A, Rauch G, Hennigs A, Richter H, Domschke C, Schuetz F, Sohn C, Schneeweiss A, Heil J. Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response? Annals of Surgical Oncology. PMID 26467456 DOI: 10.1245/s10434-015-4918-0 |
0.098 |
|
| 2012 |
Heil J, Carolus A, Dahlkamp J, Golatta M, Domschke C, Schuetz F, Blumenstein M, Rauch G, Sohn C. Objective assessment of aesthetic outcome after breast conserving therapy: subjective third party panel rating and objective BCCT.core software evaluation. Breast (Edinburgh, Scotland). 21: 61-5. PMID 21852135 DOI: 10.1016/j.breast.2011.07.013 |
0.097 |
|
| 2007 |
Schuetz F, Diel IJ, Pueschel M, von Holst T, Solomayer EF, Lange S, Sinn P, Bastert G, Sohn C. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy. American Journal of Obstetrics and Gynecology. 196: 342.e1-9. PMID 17403414 DOI: 10.1016/j.ajog.2006.10.901 |
0.097 |
|
| 2016 |
von Au A, Milloth E, Diel I, Stefanovic S, Hennigs A, Wallwiener M, Heil J, Golatta M, Rom J, Sohn C, Schneeweiss A, Schuetz F, Domschke C. Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial. Oncotargets and Therapy. 9: 4173-4180. PMID 27468239 DOI: 10.2147/OTT.S103130 |
0.097 |
|
| 2017 |
Fremd C, Hack CC, Schneeweiss A, Rauch G, Wallwiener D, Brucker SY, Taran FA, Hartkopf A, Overkamp F, Tesch H, Fehm T, Hadji P, Janni W, Lüftner D, Lux MP, ... ... Schuetz F, et al. Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network. Archives of Gynecology and Obstetrics. PMID 28331996 DOI: 10.1007/s00404-017-4348-2 |
0.097 |
|
| 2015 |
von Au A, Weiler U, Stefanovic S, Wallwiener M, Heil J, Golatta M, Rom J, Sohn C, Schneeweiss A, Schuetz F, Domschke C. Breast cancer presentation and therapy in migrant versus native German patients: contrasting and convergent data of a retrospective monocentric study. Archives of Gynecology and Obstetrics. PMID 26538355 DOI: 10.1007/s00404-015-3938-0 |
0.096 |
|
| 2004 |
Beckhove P, Feuerer M, Dolenc M, Schuetz F, Choi C, Sommerfeldt N, Schwendemann J, Ehlert K, Altevogt P, Bastert G, Schirrmacher V, Umansky V. Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors. The Journal of Clinical Investigation. 114: 67-76. PMID 15232613 DOI: 10.1172/JCI20278 |
0.093 |
|
| 2013 |
Schmidt HH, Ge Y, Hartmann FJ, Conrad H, Klug F, Nittel S, Bernhard H, Domschke C, Schuetz F, Sohn C, Beckhove P. HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patients. Oncoimmunology. 2: e24962. PMID 23894725 DOI: 10.4161/onci.24962 |
0.093 |
|
| 2013 |
Golatta M, Franz D, Harcos A, Junkermann H, Rauch G, Scharf A, Schuetz F, Sohn C, Heil J. Interobserver reliability of automated breast volume scanner (ABVS) interpretation and agreement of ABVS findings with hand held breast ultrasound (HHUS), mammography and pathology results. European Journal of Radiology. 82: e332-6. PMID 23540947 DOI: 10.1016/j.ejrad.2013.03.005 |
0.093 |
|
| 2011 |
Schuetz F. Adjuvant Systemic Therapy of Breast Cancer. Breast Care (Basel, Switzerland). 6: 179-183. PMID 21779222 DOI: 10.1159/000329336 |
0.092 |
|
| 2017 |
von Au A, Klotzbuecher M, Uhlmann L, Boudewijns M, Michel L, Wallwiener M, Heil J, Golatta M, Rom J, Sohn C, Schneeweiss A, Schuetz F, Domschke C. Impact of reproductive factors on breast cancer subtypes in postmenopausal women: a retrospective single-center study. Archives of Gynecology and Obstetrics. PMID 28176013 DOI: 10.1007/s00404-017-4298-8 |
0.091 |
|
| 2016 |
Hennigs A, Fuchs V, Sinn HP, Riedel F, Rauch G, Smetanay K, Golatta M, Domschke C, Schuetz F, Schneeweiss A, Sohn C, Heil J. Do Patients After Reexcision Due to Involved or Close Margins Have the Same Risk of Local Recurrence as Those After One-Step Breast-Conserving Surgery? Annals of Surgical Oncology. PMID 26732272 DOI: 10.1245/s10434-015-5067-1 |
0.09 |
|
| 2013 |
Heil J, Rauch G, Szabo AZ, Garcia-Etienne CA, Golatta M, Domschke C, Badiian M, Kern P, Schuetz F, Wallwiener M, Sohn C, Fries H, von Minckwitz G, Schneeweiss A, Rezai M. Breast cancer mastectomy trends between 2006 and 2010: association with magnetic resonance imaging, immediate breast reconstruction, and hospital volume. Annals of Surgical Oncology. 20: 3839-46. PMID 23838917 DOI: 10.1245/s10434-013-3097-0 |
0.089 |
|
| 2014 |
Rom J, Bechstein S, Domschke C, Golatta M, Mayer C, Heil J, Thum J, Smetanay K, Windemuth-Kieselbach C, Wallwiener M, Marme F, Schuetz F, Sohn C, Schneeweiss A. Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer. Anti-Cancer Drugs. 25: 219-24. PMID 24247203 DOI: 10.1097/CAD.0000000000000037 |
0.086 |
|
| 2008 |
Diel IJ, Jaschke A, Solomayer EF, Gollan C, Bastert G, Sohn C, Schuetz F. Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 19: 2007-11. PMID 18664560 DOI: 10.1093/annonc/mdn429 |
0.082 |
|
| 2017 |
Maier A, Heil J, Lauer A, Harcos A, Schaefgen B, von Au A, Spratte J, Riedel F, Rauch G, Hennigs A, Domschke C, Schott S, Rom J, Schuetz F, Sohn C, et al. Inter-rater reliability and double reading analysis of an automated three-dimensional breast ultrasound system: comparison of two independent examiners. Archives of Gynecology and Obstetrics. PMID 28748340 DOI: 10.1007/s00404-017-4473-y |
0.081 |
|
| 2012 |
Heil J, Breitkreuz K, Golatta M, Czink E, Dahlkamp J, Rom J, Schuetz F, Blumenstein M, Rauch G, Sohn C. Do reexcisions impair aesthetic outcome in breast conservation surgery? Exploratory analysis of a prospective cohort study. Annals of Surgical Oncology. 19: 541-7. PMID 21761099 DOI: 10.1245/s10434-011-1947-1 |
0.078 |
|
| 2014 |
Domschke C, Schuetz F. Side effects of bone-targeted therapies in advanced breast cancer. Breast Care (Basel, Switzerland). 9: 332-6. PMID 25759613 DOI: 10.1159/000368844 |
0.071 |
|
| 2013 |
Aigner J, Marmé F, Smetanay K, Schuetz F, Jaeger D, Schneeweiss A. Nab-Paclitaxel monotherapy as a treatment of patients with metastatic breast cancer in routine clinical practice. Anticancer Research. 33: 3407-13. PMID 23898112 |
0.066 |
|
| 2013 |
Stefanovic S, Schuetz F, Sohn C, Beckhove P, Domschke C. Bone marrow microenvironment in cancer patients: immunological aspects and clinical implications. Cancer Metastasis Reviews. 32: 163-78. PMID 23081701 DOI: 10.1007/s10555-012-9397-1 |
0.057 |
|
| 2015 |
Mayer C, Brucker J, Schuetz F, Domschke C, Bechstein S, Heil J, Golatta M, Wallwiener M, Sohn C, Schneeweiss A, Rom J. Efficacy and toxicity profile of pegylated liposomal doxorubicin in patients with advanced ovarian cancer. Archives of Gynecology and Obstetrics. PMID 26498757 DOI: 10.1007/s00404-015-3913-9 |
0.055 |
|
| 2016 |
Heil J, Kneser U, Hennigs A, Bieber C, Gschwendtner K, Mueller N, Rauch G, Schuetz F, Sohn C, Kremer T. Do Contralateral Prophylactic Mastectomies Help Patients? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27621389 DOI: 10.1200/JCO.2016.68.2997 |
0.044 |
|
| 2013 |
Schulz S, Sinn P, Golatta M, Rauch G, Junkermann H, Schuetz F, Sohn C, Heil J. Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy. Breast (Edinburgh, Scotland). 22: 537-42. PMID 23237921 DOI: 10.1016/j.breast.2012.11.002 |
0.037 |
|
| 2014 |
Salmen J, Neugebauer J, Fasching PA, Haeberle L, Huober J, Wöckel A, Rauh C, Schuetz F, Weissenbacher T, Kost B, Stickeler E, Klar M, Orlowska-Volk M, Windfuhr-Blum M, Heil J, et al. Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies. Breast Cancer Research and Treatment. 148: 143-51. PMID 25253172 DOI: 10.1007/s10549-014-3130-4 |
0.035 |
|
| 1980 |
Tegtmeyer P, Spillman T, Schuetz FR. Purification and characterization of the SV40 F-gene protein. Cold Spring Harbor Symposia On Quantitative Biology. 44: 159-64. PMID 6253129 |
0.029 |
|
| 2016 |
Riedel F, Fremd C, Tabatabai P, Smetanay K, Doster A, Heil J, Schuetz F, Sohn C, Hennigs A. Exam preparation course in obstetrics and gynecology for the German Medical State Examination: proof of concept and implications for the recruitment of future residents. Archives of Gynecology and Obstetrics. PMID 27506659 DOI: 10.1007/s00404-016-4168-9 |
0.026 |
|
| 2012 |
Domschke C, Strowitzki T, Huth-Kuehne A, Staritz P, Sohn C, Schuetz F. Successful in vitro fertilization and pregnancy in Glanzmann thrombasthenia. Haemophilia : the Official Journal of the World Federation of Hemophilia. 18: e380-1. PMID 22672198 DOI: 10.1111/j.1365-2516.2012.02873.x |
0.01 |
|
| Hide low-probability matches. |